表紙
市場調査レポート

世界の先進創傷治療市場

The Global Advanced Wound Care Market to 2017

発行 Espicom Business Intelligence 商品コード 140387
出版日 ページ情報 英文 258 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=101.75円で換算しております。
Back to Top
世界の先進創傷治療市場 The Global Advanced Wound Care Market to 2017
出版日: 2012年08月09日 ページ情報: 英文 258 Pages
概要

当報告書では、世界の高度創傷治療市場における製品概要、主要企業別、製品別市場シェアデータ、および成長予測をまとめ、概略以下の構成でお届けいたします。

市場概況

  • エグゼクティブサマリー
  • 背景
  • 現在の市場力学
  • 地域展望
  • 競合環境
  • 将来の市場見通し

高度創傷治療製品・技術

  • デバイスベースの創傷治療
    • 負圧創傷治療
    • 電気刺激
    • 超音波
    • 体外衝撃波治療
    • その他
  • 湿潤式創傷治療製品
    • ハイドロゲル
    • ハイドロコロイド包帯
    • アルギン酸
    • 泡状包帯
    • 複合包帯
    • ソフトシリコン包帯
    • 活性炭包帯
    • 透明フィルム包帯
    • 抗菌包帯
  • 生物製剤
    • 法規制環境
    • コラーゲンベースの創傷治療製品
    • 皮膚代替物
    • 成長因子
    • 細胞療法
    • その他の生物製剤
    • 酵素的壊死組織切除剤
  • その他

製造業者のプロファイル

  • リーダー企業
  • その他の企業

付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

Abstract

A changing industry landscape

Mergers and acquisitions have always played a key role in the advanced wound care industry and have enabled the market leaders to expand their technology to address new sections of the market and provide access to new technologies. But things are hotting up. Smith & Nephew continues to add to its portfolio with the acquisition in May 2012 of Kalypto Medical while pharmaceutical companies flex their financial muscle: Shire purchased BioHealing in June 2011 while Sanofi's purchase of Genzyme in April 2011 has introduced the new Sanofi Biosurgery division.

Private equity gets more involved

The headline acquisition of the NPWT leading company KCI by the APAX consortium is just the latest of a string of private equity transactions. Nordic Capital and Avista Capital Partners purchased ConvaTec in August 2008, Systagenix was formed in December 2008 through One Equity Partners' purchase of Ethicon Professional Wound Care, and Investor AB took full control of Mölnlycke in late 2010.

Biologics: the growth sector of the future?

With price pressures in the NPWT sector and low prices driven by high competition in the Moist Dressings sector, the spotlight has been thrown on Biologics. While all sectors are expected to return to stronger annual growth, only the biologics sector is expected to maintain double digit growth from 2015 onwards as products currently in development are launched.

Key statistics and forecasts provide a real insight to the future of this critical device sector

Wound Care Market

  • Global Wound Care Market by Product Type, 2011
  • Professional Wound Care Market by Product Type, 2011

Advanced Wound Care Market Competitors

  • Select Manufacturers' Wound Care Sales, 2005-2011 (US$ million)
  • International Manufacturers' Wound Care Sales, 2005-2011
  • Advanced Wound Care Market Shares, 2011
  • Advanced Wound Care Acquisitions, 2008-2011

Wound Care Market Dynamics

  • Professional Wound Care Market by Product Type, 2007-2011 (US$ million)
  • Professional Wound Care Market Forecast, 2012-2017 (US$ million)
  • Global Wound Care Market Growth by Product, 2012-2017 (%)

Regional Perspective

  • Advanced Wound Care Market by Region and Growth by Region, 2012-2017 (US$ million)
  • US, European and Rest of the World Markets by Major Product Type, 2011

About the Author

This report has been researched and written by senior Espicom medical market analyst Joanne Maddox. For over 10 years she has played a pivotal role in tracking trends in medical device and equipment markets and companies. A former editor of Medical Device Companies

Key statistics and forecasts provide a real insight to the future of this critical device sector

Table of Contents

MARKET OVERVIEW

  • EXECUTIVE SUMMARY
  • BACKGROUND
    • Wound Care Products
    • Fig.1: Global Wound Care Market by Product Type, 2011.
    • Advanced Wound Care
    • Complex Wounds: The Role of Advanced Wound Care
  • CURRENT MARKET DYNAMICS
    • Fig.2: Professional Wound Care Market by Product Type, 2011
    • Professional Wound Care Market by Product Type, 2007-2011 (US$ million)
    • Global Wound Care Market Growth by Product, 2008-2011 (%)
    • Establishing Safety and Effectiveness
    • Regulatory Environment
  • REGIONAL PERSPECTIVE
    • Advanced Wound Care Market by Region, 2008-2011 (US$ million)
    • Fig.3: Advanced Wound Care Market by Region, 2011
    • Fig.4: North American Market by Major Product Type, 2011
    • Fig.5: European Market by Major Product Type, 2011
  • COMPETITIVE ENVIRONMENT
    • Select Manufacturers' Wound Care Sales, 2005-2011 (US$ million)
    • Non-US Manufacturers' Wound Care Sales in Reported Currency, 2005-2011 (million)
    • Fig.6: Advanced Wound Care Market Shares, 2011
    • Changing Industry Landscape
    • Advanced Wound Care Acquisitions, 2008-2011
  • FUTURE MARKET PROSPECTS
    • Professional Wound Care Market Forecast, 2011-2017E (US$ million)
    • Global Wound Care Market Growth by Product, 2011-2017E (%)
    • Advanced Wound Care Market by Region, 2011-2017E (US$ million)
    • Advanced Wound Care Market Growth by Region, 2011-2017E (%)

ADVANCED WOUND CARE PRODUCTS & TECHNOLOGIES

  • Fig.7: Advanced Wound Care Market by Product Type, 2011
  • Fig.8: Advanced Wound Care Market by Product Type, 2017E
  • DEVICE-BASED WOUND CARE
    • Negative Pressure Wound Therapy
      • Competitive Environment
      • Fig.9: NPWT Market Share by Company, 2011
      • Market Dynamics
      • Fig.10: NPWT Market, 2006-2017E (US$ million)
      • Fig.11: NPWT Market by Region, 2011
      • Current Challenges and Opportunities in the NPWT Market
      • Safety and Effectiveness of NPWT
      • Kinetic Concepts' V.A.C. Therapy
      • Smith & Nephew's NPWT Systems
      • Boehringer Technologies' Engenex NPWT System
      • Hartmann's Vivano NPWT System
      • Genadyne Biotechnologies' A4 and XLR8 NPWT Systems
      • Getinge's WoundASSIST TNP System
      • Innovative Therapeutics' Svedman and Sved Systems
      • Medela's Invia Liberty NPWT System
      • Mölnlycke Health Care's Avance
      • Prospera's PRO NPWT Systems
      • Talley Group's Venturi Systems
      • The Medical & WoundCare Company's Exsudex
      • In Development - PolyNovo Biomaterials' NovoSorb Foam Dressing
    • Electrical Stimulation
      • BioElectronics' RecoveryRx
      • Mölnlycke Health Care's woundEL System
      • Synapse Microcurrent's Accel-Heal
      • Vomaris Innovations' Procellera
    • Ultrasound
      • Arobella Medical's Qoustic Wound Therapy System
      • Celleration's MIST Therapy System
      • Misonix' SonicOne Ultrasonic Wound Debridement System
      • NanoVibronix' PainShield and WoundShield
      • Söring's Sonoca Systems
    • Extracorporeal Shock Wave Therapy
      • SANUWAVE's dermaPACE
      • Tissue Regeneration Technologies' DermaGold
    • Other Wound Care Devices
      • IYIA Technologies' O2Misly
      • Regenesis Biomedical's Provant Wound Therapy System
      • SanoMed's SanoSkin Photizo Light Therapy Device
      • Vibrant Medical's Vibration Therapy
      • Advanced Oxygen Therapy's Topical Wound Oxygen Therapy

MOIST WOUND CARE PRODUCTS

  • Fig.12: Moist Wound Care Market, 2007-2017E (US$ million)
    • Fig.13: Moist Wound Care Market, 2007-2017E (US$ million)
    • Moist Wound Care Market, 2007-2011 (US$ million)
    • Moist Wound Care Market Forecast, 2012-2017 (US$ million)
    • Moist Wound Care Market Growth, 2008-2017E (%)
    • Fig.14: Moist Wound Care Market by Region, 2011
  • Hydrogels
    • Key Hydrogel Products and Manufacturers
    • New Hydrogel Technologies
  • Hydrocolloid Dressings
    • Key Hydrocolloid Products and Manufacturers
  • Alginates
    • Key Alginate Products and Manufacturers
  • Foam Dressings
    • Key Foam Products and Manufacturers
    • New Foam Technologies
    • Fig.15: Smith & Nephew's Exudate Management Sales, 2007-2011 (US$ million)
  • Composite Dressings
    • 3M Tegaderm Matrix Dressing with PHI technology
    • ConvaTec's Hydrofiber Dressings - AQUACEL & Versiva.
    • Smith & Nephew's DURAFIBER
    • Urgo's Lipido-Colloid Technology Dressings
    • Fig.16: Derma Sciences - Xtrasorb Revenue, 2008-2011 (US$ thousands)
  • Soft Silicone Dressings
    • Systagenix' ADAPTIC TOUCH
  • Activated Charcoal Dressings
    • Key Charcoal Products and Manufacturers
  • Transparent Film Dressings
    • Key Transparent Film Products and Manufacturers
    • 3M's Tegaderm Diamond Pattern Film Dressing
  • Antimicrobial Dressings
    • Fig.17: Antimicrobial Wound Care Market, 2007-2017E (US$ million)
    • Silver Dressings
    • Clinical Evidence
    • Key Silver Products and Manufacturers
    • Fig.18: Derma Sciences' ALGICELL Ag Revenue, 2008-2011 (US$ thousand)
    • Fig.19: Smith & Nephew's Infection Management Revenue, 2007-2011 (US$ million)
    • Honey Dressings
    • Fig.20: Derma Sciences - Medihoney Revenue, 2008-2011 (US$ thousands)
    • Iodine-based Dressings
    • PHMB Antimicrobial Dressings
    • Other Antimicrobial Dressings
    • Other Products In Development

BIOLOGICS

  • Fig.21: Wound Care Biologics Market, 2007-2017E (US$ million)
  • Regulatory Environment
  • Collagen-Based Wound Care Products
    • Human BioSciences' SkinTemp II and Medfill II
    • Collagen Matrix' Matrix Collagen Dressing
    • Covalon Technologies' Biostep and ColActive
    • Eucare Pharmaceuticals
    • Hartmann's CollaSorb
    • Innocoll's CollaRx Technology
    • Lescarden's Catrix Wound Dressing
    • Olympus Terumo Biomaterials' Terudermis Artificial Dermis
    • Synovis Life Technologies/Baxter's Unite Biomatrix
    • MedSkin Solutions Dr. Suwelack's Puracol Plus
    • Systagenix Wound Management's Collagen-Based Dressings
    • Wound Management Technologies' CellerateRx
    • Products in Development
  • Skin Substitutes
    • ACell's MatriStem
    • Anika Therapeutics' HYAFF
    • Cook Biotech's Oasis Wound Matrix Products
    • Integra LifeSciences' Collagen-Glycosaminoglycan Matrix
    • Kinetic Concepts/LifeCell's Graftjacket
    • Medestea Internazionale's Veloderm
    • MedSkin Solutions Dr. Suwelack's Matriderm
    • MiMedx' EpiFix
    • Mölnlycke's Xelma
    • Organogenesis' Apligraf
    • Promethean LifeSciences' GammaGraft and Repriza
    • Sanofi's Epicel Cultured Epidermal Autografts
    • Shire Regenerative Medicine's Dermagraft
    • UDL Laboratories/S&N's Biobrane
    • Products in Development
  • Growth Factors
    • Healthpoint Biotherapeutics' Regranex (becaplermin) Gel 0.01%
    • Kaken Pharmaceutical's Fiblast Spray
    • Autologous Growth Factor Products
  • Cell-Based Therapies
    • Avita Medical's ReCell Spray-On Skin
    • Tissue Genesis' Cell Isolation System
    • Products in Development
    • Garnet BioTherapeutics' GBT 009
  • Other Biologic Products
    • Mölnlycke's Oat Beta-Glucan
    • Polyheal's Microsphere-Based Technology
    • Products in Development
  • Enzymatic Debriding Agents
    • Healthpoint's Collagenase Santyl Ointment
    • Maggot Therapy
    • Lohmann & Rauscher
    • Products in Development
  • OTHER PRODUCTS
    • Oxygen-Based Wound Dressings
      • AcryMed's OxygeneSys Dissolved Oxygen Dressing
      • Oxygen Biotherapeutics' Wundecyte
      • sastOmed's Granulox
    • Chitosan Dressings
      • HemCon Medical Technologies
      • Marine Polymer Technologies' Talymed
      • Sangui BioTech's Chitoskin

MANUFACTURERS

  • THE MARKET LEADERS
  • 3M
    • Recent Key Events
    • Current Alliances
    • Financial Performance
    • 3M Health Care - Operating Results, 2009-2011 (US$ million)
  • Coloplast
    • Current Alliances
    • Financial Performance
    • Coloplast - Operating Results, 2007-2011 (DKr million)
    • Coloplast - Revenue by Product Line, 2007-2011 (DKr million)
    • Fig.22: Coloplast: Percentage of Revenue by Product Line, 2011
    • Fig.23: Coloplast - Wound & Skin Care Revenue, 2003-2011 (DKr million)
  • ConvaTec
    • Recent Key Events
    • Wound Care Product Portfolio
    • Current Alliances
    • Financial Performance
    • ConvaTec - Operating Results, 2009-2011 (US$ thousands)
    • Fig.24: ConvaTec: Percentage of Revenue by Product Line, 2011
    • Covidien
    • Advanced Wound Care Products
    • Financial Performance
    • Fig.25: Covidien - Revenue by Division, 2011
    • Fig.26: Covidien - Medical Supplies Revenue by Product Type, 2011
  • Hartmann Group
    • Advanced Wound Care Products
    • Current Alliances
    • Financial Performance
    • Hartmann - Operating Results, 2007-2011 (EUR million)
    • Hartmann Wound Management Results, 2007-2011 (EUR million)
    • Fig.27: Hartmann - Revenue by Division, 2011
    • Fig.28: Hartmann Wound Management - Revenue by Geographic Region, 2011
  • Kinetic Concepts
    • Recent Key Events
    • V.A.C. Therapy
    • LifeCell Products
    • Current Alliances and Contracts
    • Litigation with Wake Forest University
    • Financial Performance
    • KCI - Operating Results, Full Year 2006-9 Months 2011 (US$ million)
    • KCI - Revenue by Product Type, Full Year 2006-9 Months 2011 (US$ million)
    • KCI - AHS Revenue, Full Year 2006-9 Months 2011 (US$ million)
    • KCI - AHS Revenue by Region, 9 Months 2010-2011 (US$ million)
    • Fig.29: KCI - Percentage of AHS Revenue by Region, 9 Months 2011
    • Fig.30: KCI - Percentage of AHS Revenue by Type, 9 Months 2011
    • KCI - AHS Revenue by Region, 2006-2010 (US$ million)
  • Mölnlycke Health Care
    • Recent Key Events
    • Wound Care Portfolio
    • Mergers & Acquisitions
    • Current Alliances and Supply Contracts
    • Litigation
    • Financial Performance
    • Mölnlycke - Operating Results, 2007-2011 (EUR million)
  • Smith & Nephew
    • Recent Key Events
    • Advanced Wound Care Products
    • Current Alliances
    • Litigation with Wake Forest University and Kinetic Concepts
    • Financial Performance
    • S&N - Operating Results, 2007-2011 (US$ million)
    • S&N Advanced Wound Management Operating Results, 2007-2011 (US$ million)
    • S&N Advanced Wound Management Sales by Product & Region, 2007-2011 (US$ million)
    • Fig.31: S&N Advanced Wound Management Sales by Region, 2011
    • Fig.32: S&N Advanced Wound Management Sales by Product Type, 2011
    • Fig.33: S&N Advanced Wound Management Sales by Region, Q1 2012
  • Systagenix Wound Management
    • Recent Key Events
    • Advanced Wound Care Products
    • Wound Care Diagnostics

OTHER COMPANIES

  • Absorbest
  • ACell
  • AcryMed (Kimberly-Clark)
  • Adocia
  • Advanced Medical Solutions
    • Recent Key Events
    • Current Agreements
    • Financial Performance
    • AMS - Advanced Wound Care Division Operating Results, 2007-2011 (£ thousand)
    • Fig.34: AMS - Revenue by Division, 2011
    • Fig.35: AMS - Revenue by Geographic Region, 2011
    • Fig.36: AMS: Advanced Wound Care Sales, 2005-2011 (£ million)
  • Advancis Medical
    • Legal Proceedings
  • Agennix
  • Anika Therapeutics
  • AOTI
  • Argentum Medical
  • Arobella Medical
  • Aspen Surgical Products
  • Avita Medical.
    • Recent Key Events
    • ReCell Spray-On Skin
    • Financial Performance
    • Avita Medical/C3 - Operating Results, 2007-2011 (A$ thousand).
    • Fig.37: Avita Medical - External Revenue by Product Type, Fiscal 2011
    • Avita Medical/C3 - Regenerative Medicine Results, 2007-2011 (A$ thousand)
  • B. Braun
    • Financial Performance
    • B. Braun - Operating Results, 2007-2011 (EUR million)
    • Fig.38: B. Braun - Revenue by Division, 2011
  • BioCure
  • BioElectronics
    • Recent Key Events
    • Product Applications and Approvals
    • Distributors
    • Financial Performance
  • BioMonde/ZooBiotic
  • Biotec Pharmacon
    • Woulgan biogel
  • Boehringer Laboratories.
  • Cardium Therapeutics
    • Recent Key Events
    • Current Alliances and Contracts.
  • Celleration
  • Collagen Matrix
  • Comvita
    • Alliance with Derma Sciences
    • Legal Proceedings - Brightwake.
    • Financial Performance
    • Comvita - Operating Results, 2008-2012 (NZ$ million)
    • Fig.39: Comvita - Revenue by Division, 2012
    • Fig.40: Comvita: Medical Sales, 2007-2012 (NZ$ million)
  • Concept Health/Gentell
  • Covalon Technologies
    • Recent Key Events
    • Financial Performance
    • Covalon Technologies - Operating Results, 2007-2011 (C$ million)
    • Fig.41: Covalon Technologies: Advanced Wound Care Sales, 2006-2011 (C$)*
  • Crawford Healthcare
    • Current Agreements
    • Fig.42: Ark Therapeutics: Wound Care Sales, 2005-2010 (£ thousand)
  • curasan
    • Cytomedix
    • AutoloGel System
    • Recent Developments
    • Financial Performance
    • Cytomedix - Operating Results, 2007-2011 (US$ thousand)
    • Fig.43: Cytomedix: AutoloGel Product Sales, 2005-2011 (US$ thousand)
  • DermaRite Industries
  • Derma Sciences
    • Recent Key Events
    • Advanced Wound Care Products
    • Research & Development
  • Current Alliances and Licensing Agreements
  • Financial Performance
    • Derma Sciences - Operating Results, 2007-2011 (US$ million)
    • Derma Sciences - Advanced Wound Care Division Results, 2010-2011 (US$ thousand)
    • Derma Sciences' Advanced Wound Care Sales by Product, 2007-2011 (US$ thousand)
    • Fig.44: Derma Sciences - Net Sales by Division, 2011
    • Fig.45: Derma Sciences - Advanced Wound Care Sales by Key Product, 2011
  • DeRoyal
  • Eucare Pharmaceuticals
  • Ferris
  • FibroGen
  • First Water
  • Garnet BioTherapeutics
  • Genadyne Biotechnologies
  • Getinge
  • HealOr
  • Healthpoint Biotherapeutics
    • Recent Key Events
    • Advanced Wound Care Products
    • Research and Development
  • HemCon Medical Technologies
    • Recent Key Events
    • Current Alliances
  • Hollister Wound Care
  • Human BioSciences
  • Hydrofera
  • Innocoll
    • Products in Development
  • Innovative Therapies
    • Litigation with Kinetic Concepts and Wake Forest University
  • Integra LifeSciences Holdings
    • Integra LifeSciences - Operating Results, 2007-2011 (US$ million)
  • IYIA Technologies
  • Kaken Pharmaceutical
  • Kikgel
  • Kuros Biosurgery
  • Laboratoires Brothier
  • Lescarden
    • Financial Performance
  • LM Farma
  • Lohmann & Rauscher
  • Marine Polymer Technologies
    • Litigation with HemCon Medical Technologies
  • Medela
  • Medestea Internazionale
  • MediWound
    • Polyheal
  • MedSkin Solutions Dr. Suwelack
  • Milliken Chemical
  • MiMedx Group
  • Misonix
    • Current Alliances
    • Financial Performance
  • Nanotherapeutics
  • NanoVibronix
  • Noble Biomaterials
  • Oculus Innovative Sciences
    • Current Alliances and Contracts.
    • Financial Performance
    • Oculus - Operating Results, 2008-2012 (US$ thousand)
  • Olympus Terumo Biomaterials
  • Organogenesis
    • Armed Forces Institute of Regenerative Medicine
  • Osiris Therapeutics
  • Oxygen Biotherapeutics.
  • Phytoceuticals
  • PolyNovo Biomaterials
    • NovoSkin and NovoWound
  • Promethean LifeSciences
  • Prospera
  • Quick-Med Technologies.
    • Recent Key Events
    • Licensing and Development Agreements
    • Financial Performance
    • Quick-Med Technologies - Operating Results, 2007-2011 (US$ thousand)
  • RegeneRx Biopharmaceuticals
    • Current Alliances
  • Regenesis Biomedical
  • SafeBlood Technologies.
  • Sangui BioTech International
  • Sanofi Biosurgery
  • SanoMed Manufacturing
  • SANUWAVE Health
    • dermaPACE
    • Financial Performance
    • SANUWAVE Health - Operating Results, 2008-2011 (US$ thousand)
  • Shire Regenerative Medicine
  • Söring
  • Southwest Technologies.
  • Synapse Microcurrent
  • Synovis Life Technologies (Baxter)
  • Talley Group
  • The Medical & WoundCare Company
  • Tissue Genesis
  • Tissue Regeneration Technologies
  • Triticum
  • UDL Laboratories
  • ULURU
    • Recent Key Events
    • Financial Performance
    • ULURU - Operating Results, 2007-2011 (US$ million).
  • Urgo
    • Financial Performance
    • Urgo - Operating Results, 2007-2011 (EUR million)
    • Fig.46: Urgo - Revenue by Product Line, 2011
  • Vibrant Medical
  • Vomaris Innovations
  • Wound Management Technologies
    • Financial Performance
    • Wound Management Technologies - Operating Results, 2007-2011 (US$ thousand)

APPENDICES

  • APPENDIX 1 - LIST OF ABBREVIATIONS
  • APPENDIX 2 - REPORT METHODOLOGY
    • Secondary Sources
    • Market forecasts
Back to Top